The CCR2 Inhibitor Propagermanium Attenuates Diet-Induced Insulin Resistance, Adipose Tissue Inflammation and Non-Alcoholic Steatohepatitis

Author(s):
Mulder, P.; Hoek, A.M. van den; Kleemann, R.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-01-11
Language
English
Is part of
PLoS ONE (2017), No. 1
hdl
1887/114031
doi
10.1371/journal.pone.0169740